These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38433326)

  • 1. The impact of COVID-19 and vaccination status on outcomes in veterans with head and neck squamous cell carcinoma.
    Johns JD; Choe EJ; Chisolm PF; Pothast MJ; Randolph JR; Chou J; Maxwell JH
    Head Neck; 2024 Jul; 46(7):1698-1705. PubMed ID: 38433326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment outcomes in veterans with HPV-positive head and neck cancer.
    Feinstein AJ; Shay SG; Chang E; Lewis MS; Wang MB
    Am J Otolaryngol; 2017; 38(2):188-192. PubMed ID: 28342482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of Multidisciplinary Care of Head and Neck Squamous Cell Carcinoma in Medicare Patients.
    Hansen CC; Egleston B; Leachman BK; Churilla TM; DeMora L; Ebersole B; Bauman JR; Liu JC; Ridge JA; Galloway TJ
    JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1136-1146. PubMed ID: 33090191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.
    Bauml JM; Vinnakota R; Anna Park YH; Bates SE; Fojo T; Aggarwal C; Limaye S; Damjanov N; Di Stefano J; Ciunci C; Genden EM; Wisnivesky JP; Ferrandino R; Mamtani R; Langer CJ; Cohen RB; Sigel K
    J Natl Cancer Inst; 2019 May; 111(5):490-497. PubMed ID: 30239887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk and incidence of head and neck cancers in veterans living with HIV and matched HIV-negative veterans.
    Mazul AL; Hartman CM; Mowery YM; Kramer JR; White DL; Royse KE; Raychaudhury S; Sandulache VC; Ahmed ST; Zevallos JP; Richardson PA; Sikora AG; Chiao EY
    Cancer; 2022 Sep; 128(18):3310-3318. PubMed ID: 35867552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and Impact of HPV-Associated p16 Expression on Head and Neck Squamous Cell Carcinoma in Thai Patients.
    Jiarpinitnun C; Larbcharoensub N; Pattaranutaporn P; Chureemas T; Juengsamarn J; Trachu N; Lukerak S; Chansriwong P; Ngamphaiboon N
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1679-1687. PubMed ID: 32592364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer: A US Nationwide Veterans Affairs Study.
    Wu JT; La J; Branch-Elliman W; Huhmann LB; Han SS; Parmigiani G; Tuck DP; Brophy MT; Do NV; Lin AY; Munshi NC; Fillmore NR
    JAMA Oncol; 2022 Feb; 8(2):281-286. PubMed ID: 34854921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs data.
    Bauml JM; Vinnakota R; Anna Park YH; Bates SE; Fojo T; Aggarwal C; Di Stefano J; Knepley C; Limaye S; Mamtani R; Wisnivesky J; Damjanov N; Langer CJ; Cohen RB; Sigel K
    Cancer; 2019 Feb; 125(3):406-415. PubMed ID: 30341983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
    Huang SH; O'Sullivan B; Su J; Ringash J; Bratman SV; Kim J; Hosni A; Bayley A; Cho J; Giuliani M; Hope A; Spreafico A; Hansen AR; Siu LL; Gilbert R; Irish JC; Goldstein D; de Almeida J; Tong L; Xu W; Waldron J
    Cancer; 2020 Aug; 126(15):3426-3437. PubMed ID: 32478895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes Among Patients With Mucosal Head and Neck Squamous Cell Carcinoma Treated With Checkpoint Inhibitors.
    Hobday SB; Brody RM; Kriegsman B; Basu D; Newman J; Cohen RB; Lukens JN; Singh A; D'Avella CA; Sun L
    JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):918-926. PubMed ID: 35980666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck - results from an unselected cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
    Schüttrumpf L; Marschner S; Scheu K; Hess J; Rietzler S; Walch A; Baumeister P; Kirchner T; Ganswindt U; Zitzelsberger H; Belka C; Maihoefer C
    Radiat Oncol; 2020 Jan; 15(1):7. PubMed ID: 31906998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and survival for oropharynx and non-oropharynx head and neck cancers among veterans living with HIV.
    Mazul AL; Hartman C; Kramer J; White DL; Royse K; Raychaudhury S; Sandulache V; Ahmed ST; Richardson P; Sikora AG; Chiao E
    Cancer Med; 2020 Dec; 9(24):9326-9335. PubMed ID: 33094910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definitive radiation with concurrent cetuximab vs. radiation with or without concurrent cytotoxic chemotherapy in older patients with squamous cell carcinoma of the head and neck: Analysis of the SEER-medicare linked database.
    Zandberg DP; Cullen K; Bentzen SM; Goloubeva OG
    Oral Oncol; 2018 Nov; 86():132-140. PubMed ID: 30409293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving access and timeliness of care for veterans with head and neck squamous cell carcinoma: A multidisciplinary team's approach.
    Patil RD; Meinzen-Derr JK; Hendricks BL; Patil YJ
    Laryngoscope; 2016 Mar; 126(3):627-31. PubMed ID: 26267427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory and pulmonary complications in head and neck cancer patients: Evidence-based review for the COVID-19 era.
    Silverman DA; Lin C; Tamaki A; Puram SV; Carrau RL; Seim NB; Eskander A; Rocco JW; Old MO; Kang SY
    Head Neck; 2020 Jun; 42(6):1218-1226. PubMed ID: 32343013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Vaccination Status and Mortality Among Intubated Patients With COVID-19-Related Acute Respiratory Distress Syndrome.
    Grapsa E; Adamos G; Andrianopoulos I; Tsolaki V; Giannakoulis VG; Karavidas N; Giannopoulou V; Sarri K; Mizi E; Gavrielatou E; Papathanakos G; Mantzarlis KD; Mastora Z; Magira E; Koulouras V; Kotanidou A; Siempos II
    JAMA Netw Open; 2022 Oct; 5(10):e2235219. PubMed ID: 36205996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-HPV-Related Head and Neck Squamous Cell Carcinoma in a Young Patient Cohort.
    Dougherty MI; Dougherty W; Kain JJ; Hughley BB; Shonka DC; Fedder KL; Jameson MJ
    Ear Nose Throat J; 2021 Dec; 100(10_suppl):1101S-1106S. PubMed ID: 32584613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Associated With Severe COVID-19 Among Vaccinated Adults Treated in US Veterans Affairs Hospitals.
    Vo AD; La J; Wu JT; Strymish JM; Ronan M; Brophy M; Do NV; Branch-Elliman W; Fillmore NR; Monach PA
    JAMA Netw Open; 2022 Oct; 5(10):e2240037. PubMed ID: 36264571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 mRNA vaccine effectiveness against hospitalisation and death in veterans according to frailty status during the SARS-CoV-2 delta (B.1.617.2) variant surge in the USA: a retrospective cohort study.
    Tang F; Hammel IS; Andrew MK; Ruiz JG
    Lancet Healthy Longev; 2022 Sep; 3(9):e589-e598. PubMed ID: 35935474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-diagnosis aspirin use and survival in veterans with head and neck cancer.
    Lumley CJ; Kaffenberger TM; Desale S; Tefera E; Han CJ; Rafei H; Maxwell JH
    Head Neck; 2019 May; 41(5):1220-1226. PubMed ID: 30537085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.